Page results
-
The Bidborough House NHS Vaccination Centre has now closed.
-
Patient information leaflet for Functional Electrical Stimulation (FES) Clinic
-
Information supporting adults affected by cancer and blood conditions being treated at UCLH.
-
Information for patients having chemotherapy for ovarian, tubal or primary peritoneal cancer, or who have been newly diagnosed with pancreatic cancer or cholangiocarcinoma.
-
This page has been written by the Neuropsychiatry Department at the National Hospital for Neurology and Neurosurgery. The aim of this page is to provide general information about the procedure called Repetitive Transcranial Magnetic Stimulation (rTMS).
-
Information about the Integrated General Medicine Service at the RLHIM patient information leaflet.
-
This information has been written for patients who have been referred for High Dose Rate (HDR) brachytherapy to the oesophagus (gullet).
-
BBC News at the NHNN
-
This page has been written for patients who have been referred for High Dose Rate (HDR) brachytherapy to the bronchus
-
The sleep service at UCH is run within the department of Thoracic Medicine. We have particular expertise in the diagnosis and management of ventilatory disorders during sleep, including obstructive sleep apnoea syndrome, sleep disordered breathing and assessment of respiratory failure.
File results
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust
-
FOI/2022/0513 - Myelofibrosis treatment